Scarring Alopecia Associated With the Epidermal Growth Factor Receptor Inhibitor Erlotinib

April 2011 in “ Journal of the American Academy of Dermatology ”

Donna M. Hepper, Peggy A. Wu, Milan J. Anadkat

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on jaad.org →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib

57 citations , August 2006 in “Journal of the American Academy of Dermatology”

research Genetically Null Mice Reveal a Central Role for Epidermal Growth Factor Receptor in the Differentiation of the Hair Follicle and Normal Hair Development

107 citations , June 1997 in “PubMed”

EGFR is essential for normal hair development and follicle differentiation.

research Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure.

252 citations , November 1995 in “The EMBO Journal”